Center for Cancer Research Patient Travel

癌症研究中心患者旅行

• 批准号: 10703101
• 负责人: Cheryl Royce
• 金额: $ 606.18万
• 依托单位: DIVISION OF BASIC SCIENCES - NCI
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10703101
• 关键词: AIDS related cancer; CCR; Cancer Intervention; Clinical; Clinical Research; Clinical Research Protocols; Clinical Trials; Detection; Development; Diagnosis; Disease; Enrollment; Funding; Goals; HIV; Incidence; Malignant Neoplasms; Maryland; Methods; Mission; Molecular; Monitor; NCI Center for Cancer Research; Participant; Patients; Pre-Clinical Model; Prognosis; Screening for cancer; Services; Special Population; Transportation; Travel; United States National Institutes of Health; base; cancer prevention; clinical center; cost; new technology; novel; novel strategies; novel therapeutic intervention; translational clinical trial

The clinical research mission of the CCR is as follows: * Conduct hypothesis-based translational clinical trials that evaluate new therapeutic approaches * Develop novel approaches to early cancer detection and prevention * Develop and deliver novel technologies for molecular characterization, detection, diagnosis, and monitoring of cancer * Emphasize understudied diseases and cancers with increasing incidence, poor prognosis, or involving special populations * Develop better preclinical models and methods to expedite development of novel interventions for cancer. To accomplish these goals CCR develops and carries out clinical trials that are open to all U.S. citizens. Patients enrolled on clinical trials are treated at the NIH Clinical Center in Bethesda, Maryland and are reimbursed for their travel, lodging and meals. The CCR Office of the Clinical Director Patient Travel Service provides support for travel (long-distance transportation, per diem [meals and lodging]) for all participants (including HIV+ participants) on CCR clinical research protocols for cancer (including HIV-associated malignancies) and HIV at the NIH in Bethesda, Maryland

CCR的临床研究任务如下：*进行基于假设的转化性临床试验，评估新的治疗方法*开发新的癌症早期检测和预防方法*开发和提供癌症的分子表征、检测、诊断和监测的新技术*强调发病率增加、预后不良或涉及特殊人群的未被充分研究的疾病和癌症*开发更好的临床前模型和方法，以加快癌症新干预措施的开发。为了实现这些目标，CCR开发并进行了对所有美国公民开放的临床试验。登记参加临床试验的患者在马里兰州贝塞斯达的NIH临床中心接受治疗，并获得旅费、住宿和餐费报销。CCR临床主任办公室患者旅行社为所有参与者(包括HIV+参与者)在马里兰州贝塞斯达的NIH提供CCR癌症(包括HIV相关恶性肿瘤)和HIV临床研究方案的旅行支持(长途交通，按日[饮食])